PGC-1alpha, a new therapeutic target in Huntington's disease?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 17081970.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The coactivator PGC-1alpha is a key regulator of mitochondrial biogenesis and respiration, mediating expression of several transcription factors required for these programs. Three new studies reveal that PGC-1alpha expression is downregulated in patients with Huntington's disease (HD) and in several animal models of this neurodegenerative disorder, implicating PGC-1alpha in HD pathogenesis and providing a connection between impaired energy metabolism and neurodegeneration.
Medical subject headings
- Heat-Shock Proteins
- Huntington Disease
- Neurodegenerative Diseases
- Trans-Activators
- Transcription Factors